Frederick Toth
About Frederick Toth
Frederick Toth serves as the Senior Director of Drug Safety Operations at Nektar Therapeutics, a position he has held since 2017. He has extensive experience in drug safety and clinical operations, having worked at various pharmaceutical companies including Celgene, BioMarin, and sanofi-aventis.
Current Position at Nektar Therapeutics
Frederick Toth serves as the Senior Director of Drug Safety Operations at Nektar Therapeutics. He has held this position since 2017 and is based in the San Francisco Bay Area. In this role, he oversees drug safety operations, ensuring compliance with regulatory standards and the safety of pharmaceutical products.
Previous Experience in Drug Safety Operations
Prior to his current role, Toth worked at several prominent organizations in the field of drug safety. He was the Director of Drug Safety at Dohmen Life Science Services from 2013 to 2015. He also held the position of Clinical Safety Operations at Incyte from 2015 to 2017. His extensive experience includes a role as Senior Manager of Global Drug Safety and Risk Management at Celgene from 2009 to 2013.
Educational Background
Frederick Toth earned a Master of Public Administration (M.P.A) from Seton Hall University, where he studied from 1991 to 1993. He also holds a Bachelor of Science (B.S) in Pharmacy from Rutgers University, which he completed from 1977 to 1982. His educational background provides a strong foundation for his career in drug safety and public health.
Career History in the Pharmaceutical Industry
Toth has a diverse career in the pharmaceutical industry, with significant roles at various companies. He worked at BioMarin as Associate Director of Global Safety Services from 2006 to 2009. His earlier experience includes a nine-year tenure at sanofi-aventis, where he held multiple positions, including Principal Scientist and Manager. He also worked at Wyeth as a Medical Affairs Associate from 1996 to 1997.